Dermal Fillers
MAILI references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10913
MaiLi Define
In stock
Volume
4 x 1 mL
Laboratory
Sinclair Pharma
Origin
Schweiz
Indication
Facial wrinkles and folds, lip definition and enhancement, facial volume restoration, deep depressions, nasolabial folds, smile lines, marionette lines, scar tissue treatment, volume loss associated with HIV-associated lipoatrophy
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
MaiLi Define is a hyaluronic acid dermal filler with lidocaine, developed in Switzerland and manufactured by Sinclair Pharma from hyaluronic acid of biofermentative origin cross-linked with BDDE. Formulated for lip enhancement, correction of deep facial skin depressions and scar-tissue treatment, this MaiLi Define filler supports natural-looking results.
Key Benefits of MaiLi Define
- Supports natural-looking lip enhancement
- Helps fill and smooth deep facial depressions
- Scar-tissue treatment of structural defects of congenital or medical origin
- Cross-linked hyaluronic acid 18 mg/mL with lidocaine 3 mg/mL for injection comfort
- Hyaluronic acid cross-linked with BDDE
- CE-marked medical device (CE 2797)
Indications and Professional Use
Main indications
- Deep facial skin depressions
- Lip enhancement
- Scar-tissue treatment of structural defects of congenital or medical origin
Professional use
MaiLi Define is for use by authorised healthcare professionals only, injected into the deep dermis or lip mucosa. Composition: cross-linked (BDDE) hyaluronic acid 18 mg/mL of biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer. Supplied as four 1 mL pre-filled syringes with four 30G x 1/2" needles. Contraindicated in: known hypersensitivity to hyaluronic acid, lidocaine or amide-type local anaesthetics; history of severe allergy or anaphylaxis; autoimmune disease; porphyria; cutaneous disorders, inflammation or infection (e.g. herpes, acne) at or near the treatment site; bleeding disorders or treatment with thrombolytics or anticoagulants; tendency to keloid or hypertrophic scarring; pregnancy or breastfeeding; children.
Treatment areas
- Face, lips
Patient profile
Suitable for patients seeking correction of deep facial skin depressions or lip enhancement, or scar-tissue treatment of structural defects of congenital or medical origin, who want a lidocaine-containing filler for improved comfort during treatment. Injected into the deep dermis, or the lip mucosa for lip work.
How MaiLi Define Works
MaiLi Define is a cross-linked hyaluronic acid gel of biofermentative origin, cross-linked with BDDE, containing hyaluronic acid at 18 mg/mL with lidocaine hydrochloride 3 mg/mL to reduce discomfort during injection. It is injected into the deep dermis - or into the lip mucosa for lip enhancement - by an authorised healthcare professional, using the supplied 30G x 1/2" needle. The gel creates volume that corrects facial anatomy and is fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.
Why Order From Allpara
Allpara offers genuine, verified MAILI products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Is MaiLi Define suitable for lips?
Yes. Lip enhancement is a stated indication for MaiLi Define, injected into the lip mucosa.
Which areas can MaiLi Define treat?
Deep skin depressions at the level of the face, lip enhancement, and scar-tissue treatment of structural defects of congenital or medical origin. It is injected into the deep dermis.
What is in MaiLi Define?
Cross-linked (BDDE) hyaluronic acid at 18 mg/mL of biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer.
More from Sinclair
ELLANSÉ references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
ELLANSÉ Products
View all 2
LANLUMA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
LANLUMA Products
View all 2
PERFECTHA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
PERFECTHA Products
View all 8
SILHOUETTE SOFT references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
SILHOUETTE SOFT Products
View all 2
Needle, Cannulas & Threads
Clinic alternatives
/ Recently viewed
Pick up where you left off
MaiLi Define
In stock
CE Marked
MaiLi Define is a hyaluronic acid dermal filler with lidocaine, developed in Switzerland and manufactured by Sinclair Pharma from hyaluronic acid of biofermentative origin cross-linked with BDDE. Formulated for lip enhancement, correction of deep facial skin depressions and scar-tissue treatment, this MaiLi Define filler supports natural-looking results.
Key Benefits of MaiLi Define
- Supports natural-looking lip enhancement
- Helps fill and smooth deep facial depressions
- Scar-tissue treatment of structural defects of congenital or medical origin
- Cross-linked hyaluronic acid 18 mg/mL with lidocaine 3 mg/mL for injection comfort
- Hyaluronic acid cross-linked with BDDE
- CE-marked medical device (CE 2797)
Indications and Professional Use
Main indications
- Deep facial skin depressions
- Lip enhancement
- Scar-tissue treatment of structural defects of congenital or medical origin
Professional use
MaiLi Define is for use by authorised healthcare professionals only, injected into the deep dermis or lip mucosa. Composition: cross-linked (BDDE) hyaluronic acid 18 mg/mL of biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer. Supplied as four 1 mL pre-filled syringes with four 30G x 1/2" needles. Contraindicated in: known hypersensitivity to hyaluronic acid, lidocaine or amide-type local anaesthetics; history of severe allergy or anaphylaxis; autoimmune disease; porphyria; cutaneous disorders, inflammation or infection (e.g. herpes, acne) at or near the treatment site; bleeding disorders or treatment with thrombolytics or anticoagulants; tendency to keloid or hypertrophic scarring; pregnancy or breastfeeding; children.
Treatment areas
- Face, lips
Patient profile
Suitable for patients seeking correction of deep facial skin depressions or lip enhancement, or scar-tissue treatment of structural defects of congenital or medical origin, who want a lidocaine-containing filler for improved comfort during treatment. Injected into the deep dermis, or the lip mucosa for lip work.
How MaiLi Define Works
MaiLi Define is a cross-linked hyaluronic acid gel of biofermentative origin, cross-linked with BDDE, containing hyaluronic acid at 18 mg/mL with lidocaine hydrochloride 3 mg/mL to reduce discomfort during injection. It is injected into the deep dermis - or into the lip mucosa for lip enhancement - by an authorised healthcare professional, using the supplied 30G x 1/2" needle. The gel creates volume that corrects facial anatomy and is fully resorbed over time; how long the effect lasts depends on the quantity injected, the depth of placement and the patient's metabolism.
Why Order From Allpara
Allpara offers genuine, verified MAILI products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Is MaiLi Define suitable for lips?
Yes. Lip enhancement is a stated indication for MaiLi Define, injected into the lip mucosa.
Which areas can MaiLi Define treat?
Deep skin depressions at the level of the face, lip enhancement, and scar-tissue treatment of structural defects of congenital or medical origin. It is injected into the deep dermis.
What is in MaiLi Define?
Cross-linked (BDDE) hyaluronic acid at 18 mg/mL of biofermentative origin, with lidocaine hydrochloride 3 mg/mL, in phosphate buffer.
More from Sinclair
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.